Aspira appoints three new directors, executes $2.0 million equity purchase agreement

New directors bring extensive commercial healthcare relationships to expand business development opportunities.    austin, tx / access newswire / april 8, 2025 / aspira women's health inc. ("aspira" or the "company") (nasdaq:awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of three new directors to its board of directors.
AWH Ratings Summary
AWH Quant Ranking